230 related articles for article (PubMed ID: 24563515)
1. Transcriptomic architecture of the adjacent airway field cancerization in non-small cell lung cancer.
Kadara H; Fujimoto J; Yoo SY; Maki Y; Gower AC; Kabbout M; Garcia MM; Chow CW; Chu Z; Mendoza G; Shen L; Kalhor N; Hong WK; Moran C; Wang J; Spira A; Coombes KR; Wistuba II
J Natl Cancer Inst; 2014 Mar; 106(3):dju004. PubMed ID: 24563515
[TBL] [Abstract][Full Text] [Related]
2. Genomic Landscape Established by Allelic Imbalance in the Cancerization Field of a Normal Appearing Airway.
Jakubek Y; Lang W; Vattathil S; Garcia M; Xu L; Huang L; Yoo SY; Shen L; Lu W; Chow CW; Weber Z; Davies G; Huang J; Behrens C; Kalhor N; Moran C; Fujimoto J; Mehran R; El-Zein R; Swisher SG; Wang J; Fowler J; Spira AE; Ehli EA; Wistuba II; Scheet P; Kadara H
Cancer Res; 2016 Jul; 76(13):3676-83. PubMed ID: 27216194
[TBL] [Abstract][Full Text] [Related]
3. Driver Mutations in Normal Airway Epithelium Elucidate Spatiotemporal Resolution of Lung Cancer.
Kadara H; Sivakumar S; Jakubek Y; San Lucas FA; Lang W; McDowell T; Weber Z; Behrens C; Davies GE; Kalhor N; Moran C; El-Zein R; Mehran R; Swisher SG; Wang J; Zhang J; Fujimoto J; Fowler J; Heymach JV; Dubinett S; Spira AE; Ehli EA; Wistuba II; Scheet P
Am J Respir Crit Care Med; 2019 Sep; 200(6):742-750. PubMed ID: 30896962
[No Abstract] [Full Text] [Related]
4. Characterizing the molecular spatial and temporal field of injury in early-stage smoker non-small cell lung cancer patients after definitive surgery by expression profiling.
Kadara H; Shen L; Fujimoto J; Saintigny P; Chow CW; Lang W; Chu Z; Garcia M; Kabbout M; Fan YH; Behrens C; Liu DA; Mao L; Lee JJ; Gold KA; Wang J; Coombes KR; Kim ES; Hong WK; Wistuba II
Cancer Prev Res (Phila); 2013 Jan; 6(1):8-17. PubMed ID: 23087048
[TBL] [Abstract][Full Text] [Related]
5. Smoking and cancer-related gene expression in bronchial epithelium and non-small-cell lung cancers.
Woenckhaus M; Klein-Hitpass L; Grepmeier U; Merk J; Pfeifer M; Wild P; Bettstetter M; Wuensch P; Blaszyk H; Hartmann A; Hofstaedter F; Dietmaier W
J Pathol; 2006 Oct; 210(2):192-204. PubMed ID: 16915569
[TBL] [Abstract][Full Text] [Related]
6. G-protein coupled receptor family C, group 5, member A (GPRC5A) expression is decreased in the adjacent field and normal bronchial epithelia of patients with chronic obstructive pulmonary disease and non-small-cell lung cancer.
Fujimoto J; Kadara H; Garcia MM; Kabbout M; Behrens C; Liu DD; Lee JJ; Solis LM; Kim ES; Kalhor N; Moran C; Sharafkhaneh A; Lotan R; Wistuba II
J Thorac Oncol; 2012 Dec; 7(12):1747-1754. PubMed ID: 23154545
[TBL] [Abstract][Full Text] [Related]
7. Overexpressed LAPTM4B-35 is a risk factor for cancer recurrence and poor prognosis in non-small-cell lung cancer.
Kong F; Gao F; Chen J; Sun Y; Zhang Y; Liu H; Li X; Yang P; Zheng R; Liu G; Jia Y
Oncotarget; 2016 Aug; 7(35):56193-56199. PubMed ID: 27486880
[TBL] [Abstract][Full Text] [Related]
8. LAPTM4B is associated with poor prognosis in NSCLC and promotes the NRF2-mediated stress response pathway in lung cancer cells.
Maki Y; Fujimoto J; Lang W; Xu L; Behrens C; Wistuba II; Kadara H
Sci Rep; 2015 Sep; 5():13846. PubMed ID: 26343532
[TBL] [Abstract][Full Text] [Related]
9. Molecular profiles of non-small cell lung cancers in cigarette smoking and never-smoking patients.
Szymanowska-Narloch A; Jassem E; Skrzypski M; Muley T; Meister M; Dienemann H; Taron M; Rosell R; Rzepko R; Jarząb M; Marjański T; Pawłowski R; Rzyman W; Jassem J
Adv Med Sci; 2013; 58(2):196-206. PubMed ID: 24451080
[TBL] [Abstract][Full Text] [Related]
10. Unique Immune Gene Expression Patterns in Bronchoalveolar Lavage and Tumor Adjacent Non-Neoplastic Lung Tissue in Non-Small Cell Lung Cancer.
Kuo CS; Liu CY; Pavlidis S; Lo YL; Wang YW; Chen CH; Ko HW; Chung FT; Lin TY; Wang TY; Lee KY; Guo YK; Wang TH; Yang CT
Front Immunol; 2018; 9():232. PubMed ID: 29483918
[TBL] [Abstract][Full Text] [Related]
11. ARRB1-mediated regulation of E2F target genes in nicotine-induced growth of lung tumors.
Dasgupta P; Rizwani W; Pillai S; Davis R; Banerjee S; Hug K; Lloyd M; Coppola D; Haura E; Chellappan SP
J Natl Cancer Inst; 2011 Feb; 103(4):317-33. PubMed ID: 21212384
[TBL] [Abstract][Full Text] [Related]
12. Loss of transforming growth factor beta type II receptor increases aggressive tumor behavior and reduces survival in lung adenocarcinoma and squamous cell carcinoma.
Malkoski SP; Haeger SM; Cleaver TG; Rodriguez KJ; Li H; Lu SL; Feser WJ; Barón AE; Merrick D; Lighthall JG; Ijichi H; Franklin W; Wang XJ
Clin Cancer Res; 2012 Apr; 18(8):2173-83. PubMed ID: 22399565
[TBL] [Abstract][Full Text] [Related]
13. Genome-Wide Gene Expression Changes in the Normal-Appearing Airway during the Evolution of Smoking-Associated Lung Adenocarcinoma.
Kantrowitz J; Sinjab A; Xu L; McDowell TL; Sivakumar S; Lang W; Nunomura-Nakamura S; Fukuoka J; Nemer G; Darwiche N; Chami H; Tfayli A; Wistuba II; Scheet P; Fujimoto J; Spira AE; Kadara H
Cancer Prev Res (Phila); 2018 Apr; 11(4):237-248. PubMed ID: 29382653
[TBL] [Abstract][Full Text] [Related]
14. Integrating Tumor and Stromal Gene Expression Signatures With Clinical Indices for Survival Stratification of Early-Stage Non-Small Cell Lung Cancer.
Gentles AJ; Bratman SV; Lee LJ; Harris JP; Feng W; Nair RV; Shultz DB; Nair VS; Hoang CD; West RB; Plevritis SK; Alizadeh AA; Diehn M
J Natl Cancer Inst; 2015 Oct; 107(10):. PubMed ID: 26286589
[TBL] [Abstract][Full Text] [Related]
15. An epigenetic auto-feedback loop regulates TGF-β type II receptor expression and function in NSCLC.
Yang S; Cho YJ; Jin L; Yuan G; Datta A; Buckhaults P; Datta PK
Oncotarget; 2015 Oct; 6(32):33237-52. PubMed ID: 26356817
[TBL] [Abstract][Full Text] [Related]
16. Neuroepithelial transforming gene 1 functions as a potential prognostic marker for patients with non-small cell lung cancer.
Fang L; Zhu J; Ma Y; Hong C; Xiao S; Jin L
Mol Med Rep; 2015 Nov; 12(5):7439-46. PubMed ID: 26459749
[TBL] [Abstract][Full Text] [Related]
17. Defective expression of transforming growth factor beta receptor type II is associated with CpG methylated promoter in primary non-small cell lung cancer.
Zhang HT; Chen XF; Wang MH; Wang JC; Qi QY; Zhang RM; Xu WQ; Fei QY; Wang F; Cheng QQ; Chen F; Zhu CS; Tao SH; Luo Z
Clin Cancer Res; 2004 Apr; 10(7):2359-67. PubMed ID: 15073112
[TBL] [Abstract][Full Text] [Related]
18. The expression of p33(ING1), p53, and autophagy-related gene Beclin1 in patients with non-small cell lung cancer.
Liu J; Lin Y; Yang H; Deng Q; Chen G; He J
Tumour Biol; 2011 Dec; 32(6):1113-21. PubMed ID: 21779982
[TBL] [Abstract][Full Text] [Related]
19. Significance of DEK overexpression for the prognostic evaluation of non-small cell lung carcinoma.
Liu X; Qi D; Qi J; Mao Z; Li X; Zhang J; Li J; Gao W
Oncol Rep; 2016 Jan; 35(1):155-62. PubMed ID: 26530274
[TBL] [Abstract][Full Text] [Related]
20. Analysis of GAGE, NY-ESO-1 and SP17 cancer/testis antigen expression in early stage non-small cell lung carcinoma.
Gjerstorff MF; Pøhl M; Olsen KE; Ditzel HJ
BMC Cancer; 2013 Oct; 13():466. PubMed ID: 24103781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
